Editorial Picks
Best Rejuran Clinics in Korea — 2026 Guide
A national survey of polynucleotide skin booster providers across the Seoul medical-tourism corridor.
For the international patient comparing Korean Rejuran providers from outside the country, the product is one of the more legible items in the regenerative-injectable cabinet. Rejuran is a salmon-derived polynucleotide skin booster manufactured by Pharma Research (Korea), approved domestically as a medical device, positioned as a tissue-repair biostimulator delivered through mesotherapy injection. It is not, in the strict sense, a filler. The reading that follows is national rather than city-focused: eight Korean clinics, with operations concentrated in the Seoul medical-tourism corridor. The framing is comparative — what each room actually offers the visiting patient, who operates it, and what protocol is published in writing. The Korean clinical literature reports the platform as well tolerated in the indication for which it was designed, and the better operators publish reconstitution timing and session cadence in advance rather than at the consultation desk.
What to look for in a Korean Rejuran clinic
A Rejuran-capable practice rests on three operational variables. The first is operator continuity: polynucleotide mesotherapy is technique-sensitive, and the clinic that publishes which named physician administers the injection — not a junior nurse with the doctor on review — is the clinic that has industrialised the protocol. The second is reconstitution and storage discipline: Rejuran is supplied as a pre-filled syringe, and the operator who confirms cold-chain handling and disposes of partial syringes without re-dilution is the operator one trusts. The third is session-cadence honesty: the Korean protocol calls for three to four sessions at three-to-four-week intervals, with a meaningful readout at week eight to twelve. A clinic that promises single-session transformation has misunderstood the platform. Korean medical law requires physician administration; what separates the better operators is what sits above that floor — consultations that map injection zones in writing, multilingual coordinators who survive a real-time test, and willingness to decline a weak indication. International patients should ask, before the deposit transfers, which physician will hold the syringe on the day.
Eight Korean clinics worth a closer reading
What follows is an editorial discovery — not a national ranking. The Korean Rejuran market is Seoul-concentrated, and the eight clinics below are read for the texture of their published protocol rather than for marketing position.
BLS Clinic Main Branch (Gangnam) 💬
A long-running Gangnam practice with over eighteen years of operational tenure and four named operating physicians (Yi, Cho, Song, Noh) on the published roster. The skin booster menu lists Rejuran alongside exosome and laser toning. The practice hosts Korean academic forums and has been featured on MBC and SBS, an institutional differentiator the international patient can verify before booking.
Muse Clinic (Gangnam)
Operates in Gangnam since 2013 under CEO Ha Eun-hwan, with the skin booster menu listing Rejuran alongside Botox, fillers, and Thermage. The practice is built around the medical-spa register rather than the multi-device flagship register — narrower menu, longer institutional history. The published business registration and the twelve-year operational tenure are the verifiable differentiators for the visiting international patient.
Cellin Clinic Myeongdong 💬
Medical Director Dr. Kyoung-min Min operates the Myeongdong room with Seoul National University credentials and memberships across KASLS, KOAT, KALDAT, and KFERA. The skin booster menu lists Rejuran alongside Onda, Ultherapy Prime, Thermage FLX, and INMODE. The Myeongdong geography matters for the international patient routing through downtown rather than Cheongdam.
LIFTIQUE Skin Clinic (Gangnam) 💬
A Sinsa-Gangnam board-certified dermatology practice with three named dermatologists (Sangmyung Park, Yong-yon Won, Hyo-yoon Kim) and advanced diagnostic systems (Mark-Vu, Morpheus 3D) for pre-treatment imaging. The skin booster menu lists Rejuran alongside Juvelook and exosome therapy. Operating tempo is measured rather than volume-driven, with named-physician continuity across the booster series for the international patient.
Peau Reve Skin Clinic (Cheongdam) 💬
A reservation-only Cheongdam room with two exclusive hours per patient and Thermage FLX Master Doctor plus Ultherapy Prime Gold Certified designations. The skin booster menu lists Rejuran Healer alongside Juvelook and exosome, paired with Thermage FLX, Ultherapy Prime, and PDO thread lifting. Operating tempo allows unhurried consultations and anatomically mapped injection planning for the visiting international patient.
Lienjang Clinic (Gangnam)
Operating since 2004 with a dedicated resident anesthesiologist on staff and multi-country branches in Tokyo and Osaka. The skin booster menu lists Rejuran Healer alongside Lumivion and exosome, paired with a deep lifting cabinet (Ultherapy Prime, Thermage FLX, Oligio, Linear Z, ONDA, Sofwave). The two-decade institutional age and the international-branch infrastructure are the verifiable differentiators.
Umi Skin Clinic (Myeongdong)
A Myeongdong K-beauty dermatology practice under named Director Dr. Jong Woo Yoon, with the injectable menu listing Rejuran alongside Sculptra, PRP, and mesotherapy vitamins. The lifting cabinet pairs Ultherapy, Thermage, and PicoSure. The Myeongdong geography and the named-director continuity are the verifiable differentiators for the visiting international patient routing through downtown.
Ever Skin Clinic Apgujeong
An Apgujeong board-certified dermatology practice awarded twice in the same calendar year among Gangnam's published satisfaction recognitions and named the only dermatology clinic in that award. The skin booster menu lists Rejuran alongside exosome, paired with Ultherapy and thread lifting. The dual annual award and the published top-2% credential are the editorial differentiators for the visiting patient.
What Rejuran treatment actually is
Rejuran is a salmon-derived polynucleotide (PN) skin booster manufactured by Pharma Research (Korea), approved domestically as a medical device for mesotherapy-injection tissue repair. The mechanism is fibroblast signalling rather than volumetric filling: polynucleotide fragments derived from salmon DNA prompt resident fibroblasts to upregulate type I and type III collagen, hyaluronic acid synthesis, and tissue-repair cytokines over a six-to-twelve-week window. The Korean clinical literature reports measurable improvements in elasticity, hydration, and dermal density in patients who respond well, with three to four sessions at three-to-four-week intervals as standard protocol. Recovery is mild: pinpoint papules at injection sites and occasional micro-bruising for forty-eight to seventy-two hours, resolving without intervention. The platform is not a volumising filler; the patient expecting immediate cheek volume will be disappointed at week one and pleased at week eight. Candidacy excludes active pregnancy, dermatologic infection at the site, recent oral isotretinoin, and unstable autoimmune disease. The product label is salmon-derived, so a documented salmon allergy is a categorical contraindication that a competent operator screens for at the consultation rather than the injection chair.
How the eight clinics compare
What follows is categorical positioning — not a national ranking. On institutional age, BLS Main Branch publishes eighteen-plus years, Lienjang two decades, Muse twelve. On named-operator continuity, LIFTIQUE publishes three dermatologists in writing; BLS publishes four; Cellin Myeongdong publishes the medical director with Seoul National University credentials. On geography, six of eight sit in Gangnam-Cheongdam-Sinsa-Apgujeong; Cellin Myeongdong and Umi operate in Myeongdong. On platform pairing, Peau Reve and Lienjang publish the broadest device cabinets surrounding the Rejuran injection, allowing sequenced regenerative programmes. On reservation discipline, Peau Reve publishes the most explicit model — two exclusive hours per patient. On international-patient infrastructure, BLS, LIFTIQUE, Peau Reve, and Cellin Myeongdong all publish WhatsApp continuity in writing. The choice rests on which axis the patient's brief weights most heavily, and the international patient is well served by reading the published roster before transferring the deposit.
How I'd choose between these eight clinics
For the international patient comparing Korean Rejuran providers from outside the country, the choice rests on a few quiet questions. If the brief is institutional tenure and broadcaster recognition, BLS Main Branch is the first reading. If unhurried consultation register with two exclusive hours, Peau Reve. If board-certified-dermatology workflow with three named operators and diagnostic imaging, LIFTIQUE. If Myeongdong geography with named medical-director credentials, Cellin Myeongdong. If a medical-spa register with twelve-year operational tenure, Muse. If a two-decade institution with international-branch infrastructure, Lienjang. If Myeongdong K-beauty register with named-director continuity, Umi. If Apgujeong board-certified dermatology with dual annual awards, Ever Skin Clinic. The eight rooms each meet a different brief; one chooses on temperament and on which axis matters most for the multi-trip arc, not on tier.
How we read these clinics
This survey is editorial — not a ranked recommendation. We cross-checked Rejuran service offerings against the clinic database last verified 2026-05-12, on protocol publication, operator credential disclosure, and multilingual aftercare quality. The framing is national but Seoul-concentrated, reflecting market structure rather than editorial preference. We did not visit every clinic in person; where data was missing, the entry was omitted rather than embellished. The list is not exhaustive — Korea holds dozens of Rejuran-capable practices — and the editorial pick is independent of any commercial relationship. We revisit quarterly as practices change.
Frequently asked questions
Is Rejuran a filler?
No. Rejuran is a polynucleotide skin booster — a biostimulator delivered through mesotherapy injection to prompt fibroblast-mediated collagen and tissue repair. It does not add volume in the way hyaluronic acid filler does, and the patient expecting immediate volumetric change at week one has misunderstood the platform. The meaningful readout is at week eight to twelve.
How many Rejuran sessions does a typical protocol require?
Three to four sessions at three-to-four-week intervals is the standard Korean protocol, with maintenance sessions planned every six to twelve months. A senior physician should adjust cadence after the first or second session rather than committing the patient to a full programme up front.
What downtime should I plan for?
Mesotherapy-delivered Rejuran leaves pinpoint papules at injection sites for twenty-four to seventy-two hours and occasional micro-bruising in some patients. There are no incisions, no anaesthesia, no bandages. Most patients can attend a quiet dinner the same evening; visible-event scheduling is comfortable from day three.
Is Rejuran safe for patients with a salmon allergy?
No. Rejuran is derived from salmon DNA, so a documented salmon allergy is a categorical contraindication. A competent operator screens for this at the consultation rather than at the injection chair, and the international patient should disclose food allergies in writing before the consultation begins.
What does Rejuran typically cost in Korea?
A single Rejuran session in Seoul typically ranges from KRW 250,000 to KRW 600,000 depending on the variant (Healer, HB-plus, I, S) and the operator, with three-session packages priced from KRW 700,000 to KRW 1,500,000. Materially lower pricing often signals a junior-operator administration; transparent pricing in writing before booking is, in the editorial reading, a non-negotiable.
Can I combine Rejuran with lifting devices?
Yes, and most of the eight clinics above pair Rejuran with Ultherapy Prime, Thermage FLX, Sofwave, or Onda in sequenced rather than stacked sessions. The order matters: lifting first, regenerative booster a week or two later, allowing fibroblast response to settle. The senior physician should plan the sequence.
What are the realistic risks?
Mild bruising, transient redness, pinpoint papules, occasional post-inflammatory hyperpigmentation in darker phototypes, and rarely infection if aftercare is poor. Serious adverse events are uncommon when protocols are physician-administered with single-use pre-filled syringes sourced through regulated channels. A competent operator publishes the risk profile in writing at the consultation.
What credentials should I check on the physician?
Korean medical licensure verifiable through the Korean Medical Association, aesthetic medicine experience demonstrable in years rather than weeks, and — for non-Korean patients — a coordinator fluent enough to translate clinical nuance rather than appointment times. The published clinic roster should name the operating physician; an unnamed-injector room is, in the editorial reading, the one to skip.
What about visa and travel logistics?
Most visitors from the United States, Hong Kong, Singapore, Japan, and the European Union enter Korea on the standard ninety-day visa-waiver framework — no medical visa is required for the booster protocols described on this page. Booking a flight that allows three to seven days in Seoul covers a single Rejuran session with comfortable aftercare time. The Korea Health Industry Development Institute (khidi.or.kr) publishes the medical-tourism framework.
Who should not book Rejuran?
Patients seeking immediate volumetric change, single-session transformation, or a permanent result will be disappointed — the platform is a multi-session biostimulator, not a filler. Active pregnancy, recent isotretinoin, unstable autoimmune disease, documented salmon allergy, and active dermatologic infection at the injection site are categorical contraindications. Patients uncomfortable with a senior physician declining a modality on indication grounds are better served elsewhere.